Primary Site >> Stomach Cancer

Gene >> SMYD3

  • 2015
  • 2016
  • 2017
  • 2018
Ref: Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
PMID: 25471787
Ref: SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
PMID: 25472580
Ref: Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
PMID: 25627005
Ref: Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-beta1 in Gastric Cancer.
PMID: 26077602
 Ref: Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.
PMID: 26676636
 Ref: SET and MYND domain containing protein 3 in cancer.
PMID: 28123630
Ref: Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization.
PMID: 28639750
 Ref: SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
PMID: 29746925
Ref: SMYD3-associated pathway is involved in the anti-tumor effects of sulforaphane on gastric carcinoma cells.
PMID: 30263847